Scott Powell | Executive Vice President-Investor Relations |
Cameron Reynolds | President and Group Chief Executive Officer |
Terig Hughes | Group Chief Financial Officer |
Tom Butera | Chief Executive Officer-Volition Veterinary Diagnostics Development LLC |
Bruce Jackson | Benchmark |
Constantine Davides | E.F. Hutton |
Steven Ralston | Zacks |
David Westenberg | Piper Sandler |
Jim Sidoti | Sidoti & Company |
Ian Cassel | IFCM |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Full Year 2022 Earnings Conference Call. [Operator Instructions] This conference call is being recorded today, March 16, 2023.
I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations.